Stan Glezer, MD, MBA is an industry physician, passionate in optimizing value of phamecutical innovation for the patients, through partnering with the healthcare system.
Until recently, he served as Vice President of US Medical Affairs at Novo Nordisk Inc. Prior to joining Novo Nordisk, Stan has worked at Sanofi where, most recently, he led the development, regulatory submission, and launch preparation of Toujeo.
He brings with him extensive knowledge of medical affairs at an affiliate and Global level, as well as of the commercial areas of pharmacueitcal business and has held leadership roles in post-marketing research, epidemiology, medical information, medical communications, HEOR, interfacing with regulatory agencies, market access, and overall lifecycle management
Although his activities in the past few years were predominatly focused on diabetes, Stan has worked in multiple theraputic areas, including osteoporosis, oncology, immuno-inflammation, obesity, thrombosis, bleeding disorder and rare diseases. HE has a strong track record of leading the teams in establishing collaborations with healthcare providers, key opinion leaders, payers, and professional associations.
Stan received his medical training in Russia and has worked in Canada and in France for the past 20 years. He has an MBA from California Coast University and completed his graduate work in Clinical Research at McGill University.